(Q40333120)

19 September 2017

1 reference

title

Aminoadamantane derivatives (English)

1 reference

19 September 2017

Tilley JW

1

1 reference

19 September 2017

Kramer MJ

series ordinal

2

1 reference

19 September 2017

publication date

1 January 1981

1 reference

Progress in medicinal chemistry

19 September 2017

published in

1 reference

19 September 2017

volume

18

1 reference

19 September 2017

page(s)

1-44

1 reference

Antiviral agents: action and clinical use.

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Inhibitors of influenza virus replication

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Drug therapy: antiviral agents (first of two parts).

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Amantadine hydrochloride. Analysis of data related to its proposed use for prevention of A2 influenza virus disease in human beings

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Amantadine and influenza: evaluation of conflicting reports

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Sensitivity of influenza A/New Jersey/8/76 (Hsw1N1) virus to amantadine-HCl

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Use of a photodensitometric technique to quantify microscopic lung lesions in mice: Antiviral activity against swine influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Activity of Amantadine, Rimantadine, and Ribavirin Against Swine Influenza in Mice and Squirrel Monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Inhibition of dengue virus replication by amantadine hydrochloride

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

RUBELLA VIRUS: INHIBITION IN VITRO BY AMANTADINE HYDROCHLORIDE.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

ANTIVIRAL ACTIVITY OF 1-ADAMANTANAMINE (AMANTADINE).

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Inhibition of uncoating of fowl plague virus by l-adamantanamine hydrochloride

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Electron microscopic observations on the entry of influenza virus into susceptible cells

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

On the Mechanism of Inhibition of Influenza Virus Replication by Amantadine Hydrochloride

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Adamantanamine and early events following influenza virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

In vivo Selection of an Influenza A2 Strain resistant to Amantadine

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Amantadine-resistance as a Genetic Marker for Influenza Viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Antiviral mechanisms of action

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Prevention and control of influenza by chemoprophylaxis and chemotherapy. Prospects from examination of recent experience

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

From the National Institutes of Health. Report of a workshop on clinical studies of the efficacy of amantadine and rimantadine against influenza vireus

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Prevention of Russian Influenza by Amantadine

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Amantadine effect on peripheral airways abnormalities in influenza. A study in 15 students with natural influenza A infection

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Small airways dysfunction in influenza A virus infection: therapeutic role and potential mode of action of amantadine

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Amantadine: does it have a role in the prevention and treatment of influenza? A National Institutes of Health Consensus Development Conference

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Control of influenza in the hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Treatment of influenza. The therapeutic efficacy of rimantadine HC1 in a naturally occurring influenza A2 outbreak

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Therapeutic efficacy of amantadine HCl and rimantadine HCl in naturally occurring influenza A2 respiratory illness in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Effect of rimantadine on influenza virus replication

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Inhibition of influenza virus uncoating by rimantadine hydrochloride

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Inhibition of in vitro proliferative responses of human lymphocytes by rimantadine hydrochloride

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Effect of amantadine hydrochloride on the response of human lymphocytes to phytohemagglutinin

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Influenza Virus Infection in Nude Mice

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Effects of low- and high-passage influenza virus infection in normal and nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Antibody production and protection against influenza virus in immunodeficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Alpha-methyl-1-adamantane-methylamine hydrochloride: inhibition of Rous and Esh sarcoma viruses in cell culture

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

The relative potencies of anti-influenza compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Controlled trial of amantadine hydrochloride in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Amantadine in parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Clinical trial with amantadine and pemoline in elderly patients

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Considerations in the management of parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Plasma concentrations of L-dopa and 3-methoxydopa and improvement in clinical ratings and motor performance in patients with Parkinsonism treated with L-dopa alone or in combination with amantadine

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Four-year treatment of patients with parkinsonism using amantadine alone or with levodopa

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Long-term evaluation of amantadine and levodopa combination in parkinsonism by double-blind corssover analyses

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

A Double-Blind Study of Amantadine Hydrochloride versus Benztropine Mesylate in Drug-Induced Parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

A Controlled Trial of Amantadine in Drug-Induced Extrapyramidal Disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Comparison of benztropine mesylate and amantadine HCl in neuroleptic-induced extrapyramidal symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

1 reference

7 January 2021

Pharmacokinetics and Clinical Effects of Amantadine in Drug-Induced Extrapyramidal Symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Effect of amantadine on drug-induced parkisonism: relationship between plasma levels and effect

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

For mental patients, the 'cure' may be worse

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Catatonic reactions to high-potency neuroleptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Letter: Amantadine in chorea

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Creutzfeldt-Jakob disease treated with amantidine: A report of two cases

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Short report: Creutzfeldt-Jakob disease treated with amantadine

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Amantadine in senile dementia: electroencephalographic and clinical effects

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Treatment of spasmodic torticollis with amantadine: A double-blind studv

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Catecholamines and self-stimulation: The action of amantadine and its interaction with amphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Amantadine-Dopamine Interaction: Possible Mode of Action in Parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Some actions of amantadine on peripheral tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

The toxicologic and pharmacologic properties of amantadine hydrochloride.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Ultrastructural evidence of amantadine and amphetamine noradrenaline releasing action

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Amantadine: aggressive effect; effect on apomorphine-induced aggressivity in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Modification of electroshock fighting by drugs known to interact with dopaminergic and noradrenergic neurons in normal and brain lesioned rats

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Changes in dopamine agonist and antagonist activity following temporary inactivation of the neostraitum

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

A comparison of circling models for the detection of antiparkinson activity

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

A comparison between amantadine and bromocriptine using the stereotyped behaviour response test (SBR) in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

The 6-hydroxydopamine rotational model for the detection of dopamine agonist activity: reliability of effect from different locations of 6-hydroxydopamine

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Effects of dopamine analogues and antagonists on carotid body chemosensors in situ

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Antagonistic effect of cyproheptadine on neuroleptic-induced catalepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Antagonism of ethanol-evoked responses by amantadine: a possible clinical application

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

The effect of amantadine, l-DOPA, (+)-amphetamine and apomorphine on the acquisition of the conditioned avoidance response

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

The interaction of dopamine-antagonists and amantadine hydrochloride on the acquisition of the conditioned avoidance response in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

The mechanism of the hypothermic effect of amantadine in rats and mice

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Studies on the mechanism of action of amantadine

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Effect of amantadine on the rate of dopamine synthesis in rat corpus striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Urinary monoamine metabolite excretion in disorders of movement. Effects of amantadine and levodopa

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Proceedings: The effect of amantadine on the turnover of catecholamines in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Studies on the distinction between uptake inhibition and release of [3H]dopamine in rat brain tissue slices

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Selective depletion of noradrenaline: a proposed mechanism of the adrenergic neurone-blocking action of bretylium

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

On the nature of the adrenergic neuron extragranular amine binding site

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Responses of central neurones to amantadine: comparison with dopamine and amphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Responses of neurones in the cerebral cortex and caudate nucleus to amantadine, amphetamine and dopamine

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Evidence for a non-dopaminergic action of amantadine

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Comparison of neuronal responses to amantadine and rimantadine: Use of α-flupenthixol

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Opposing effects of dopaminergic to cholinergic compounds on a cerebral dopamine-activated adenylate cyclase

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Amantadine and D-145, an amantadine derivative, do not effect dopamine sensitive adenylate cyclase from the caudate-putamen of the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Effects of dopaminergic stimulants on cyclic nucleotide levels in mouse brain in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

1 reference

7 January 2021

Biochemical effects of adamantanamines, a new class of drugs with antiparkinson activity

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Induction of the platelet release reaction by concanavalin A-relation of con A binding to release and modification of release by ATP, PGE1 and amantadine

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Amantadine tremor, a 5-hydroxytryptamine-mediated response?

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Central nervous system and autonomic nervous system effects of amantadine and of some standard anti-Parkinson drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Anticholinergic and membrane activities of amantadine in neuromuscular transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Amantadine: Neuromuscular Blockade by Suppression of Ionic Conductance of the Acetylcholine Receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Acetylcholine receptor and ionic channel of Torpedo electroplax: binding of perhydrohistrionicotoxin to membrane and solubilized preparations

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

The action of amantadine on the rat uterus: Its interaction with oxytocin and the effects of several ionic modifications of the medium

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Excitation-mediating and inhibition-mediating dopamine-receptors: A new concept towards a better understanding of electrophysiological, biochemical, pharmacological, functional and clinical data

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Multiple receptors for dopamine

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Amantadine hydrochloride: alteration in peripheral circulation

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Vision loss associated with amantadine hydrochloride use

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Visual Hallucinations and Delirium During Treatment with Amantadine (Symmetrel)

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Treatment of acute amantadine toxicity with physostigmine

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Antiviral agents in influenza--summary of Influenza Workshop VIII.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Amantadine kinetics in healthy young subjects after long-term dosing

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Dopamine release and direct dopamine receptor activation in the central nervous system by D-145, an amantadine derivative

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

GABA-ergic drugs block the locomotor stimulant effects of 1,3-dimethyl-5-aminoadamantane (D-145)

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Pharmacological effects of 1,3-dimethyl-5-aminoadamantane, a new adamantane derivative

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Abolition of spinal motor disturbance by injections of dopamine receptor agonists, atropin and GABA into the caudate nucleus

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Dopaminergic stimulation enhances the utilization of noradrenaline in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Prostaglandin synthetase inhibitors and leucocytic emigration

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

The effect of dimethylaminoadamantane on neuronal membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

The depression of monosynaptically excited alpha-motoneurons during vibration reflex by dimethylaminoadamantan (DMAA).

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

The reduction of excitability of the gamma-loop by 1,3-dimethyl-5-aminoadamantane (DMAA).

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Adamantylthiourea derivatives as antiviral agents

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Antiviral agents. 6. Variation of substituents in the series of N'-substituted N-(adamantyl-(1))-thioureas

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Biologically active polycycloalkanes. 2. Antiviral 4-homoisotwistane derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

1 reference

7 January 2021

Adamantanealkanamines as potential antidepressant and anti-Parkinson agents

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Plasma and urine concentrations of a new adamantane derivative

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Analysis of 1-(2-phenyladamant-1-yl)-2-methylaminopropane as its chlorodifluoroacetyl derivative

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Interaction of phencyclidine and its new adamantyl derivatives with muscarinic receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Functional evidence for a second binding site of nicotinic antagonists using phencyclidine derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

A potential amphetamine antagonist, adamantanamine derivative of fluphenazine

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Hypo-.beta.-lipoproteinemic agents. 1. Bicyclo[2.2.2]octyloxyaniline and its derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Hypobetalipoproteinemic agents. 2. Compounds related to 4-(1-adamantyloxy)aniline

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Sulfamylurea Hypoglycemic Agents. I. Synthesis and Screening

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

Sulfamylurea hypoglycemic agents. 6. High-potency derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6468%2808%2970315-1

7 January 2021

10.1016/S0079-6468(08)70315-1

Identifiers

DOI

0 references

1 reference